About this trial
The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking resources. The two app versions each include best practice advice and guidance for quitting smoking, but one includes additional content designed for people who aren't ready to quit smoking.
The investigators hypothesize that people who receive the experimental intervention will be more likely to request additional stop-smoking resources offered through the intervention and report smoking abstinence after 6 months.
The investigators also hypothesize people assigned to the experimental app will have better app engagement and be more likely to report positive changes in their smoking behavior and use of other evidence-based stop smoking treatments that are publicly available.
Eligibility criteria
Qualifiers
18 years of age and older
Current cigarette smoker who is ambivalent about smoking
Not actively using any treatment to quit smoking
Own and regularly use a smartphone
Disqualifiers
A lifetime history of dementia or psychosis
Visual impairments that prevent viewing phone content and they lack adaptive devices
Report medical contra-indications for over-the-counter NRT use
Due to the potential for bias introduced by fraudulent participants, other exclusions will be applied to deter fraudulent enrollment.
Trial design
Treatments tested in this trial
- Control Intervention
- Experimental Intervention
Treatment groups
Sponsors and collaborators
Kaiser Permanente
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Fred Hutchinson Cancer Center
Collaborator
University of California, Davis
Collaborator